Next Science Ltd
ASX:NXS

Watchlist Manager
Next Science Ltd Logo
Next Science Ltd
ASX:NXS
Watchlist
Price: 0.14 AUD Market Closed
Market Cap: 41m AUD

Next Science Ltd
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Next Science Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Next Science Ltd
ASX:NXS
Revenue
$22.8m
CAGR 3-Years
37%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Nanosonics Ltd
ASX:NAN
Revenue
AU$198.6m
CAGR 3-Years
18%
CAGR 5-Years
15%
CAGR 10-Years
24%
Polynovo Ltd
ASX:PNV
Revenue
AU$127.7m
CAGR 3-Years
46%
CAGR 5-Years
42%
CAGR 10-Years
98%
SDI Ltd
ASX:SDI
Revenue
AU$110.4m
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
5%
Ansell Ltd
ASX:ANN
Revenue
$2B
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
2%
L
Lumos Diagnostics Holdings Ltd
ASX:LDX
Revenue
$12.4m
CAGR 3-Years
2%
CAGR 5-Years
17%
CAGR 10-Years
N/A
No Stocks Found

Next Science Ltd
Glance View

Market Cap
40.9m AUD
Industry
Health Care

Next Science Ltd. engages in the research, development, and distribution of technologies with bacterial issue application. The company is headquartered in Chatswood, New South Wales. The company went IPO on 2019-04-18. The firm's principal activities include development and commercialization of XBIO technology. The XBIO technology is a non-toxic technology used in solving the problems of bacterial biofilms. The firm's product includes XPERIENCE, SURGX, BACTISURE and BLASTX. The XPERIENCE product is an antimicrobial solution used to prevent surgical site infections by rinsing away debris and microorganisms. SURGX Sterile Antimicrobial Gel is used to reduce surgical site and post-surgical infections by destroying planktonic and biofilm-based bacteria within the gel. The BLASTX is an antimicrobial wound gel.

NXS Intrinsic Value
0.27 AUD
Undervaluation 48%
Intrinsic Value
Price

See Also

What is Next Science Ltd's Revenue?
Revenue
22.8m USD

Based on the financial report for Dec 31, 2024, Next Science Ltd's Revenue amounts to 22.8m USD.

What is Next Science Ltd's Revenue growth rate?
Revenue CAGR 5Y
41%

Over the last year, the Revenue growth was 3%. The average annual Revenue growth rates for Next Science Ltd have been 37% over the past three years , 41% over the past five years .

Back to Top